- Human（1）
No data
- His Tag & Avi Tag（1）
No data
- HEK293（1）
No data
- Biotin-labeled（1）
No data
- RUO（1）
No data
- No（1）
No data
- 25ug/$125.00
- 200ug/$700.00
No data
| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| HLA-B*1501 & B2M | Biotinylated Human HLA-B*15:01&B2M Monomer Protein (Peptide free, MALS verified) |  Human | HEK293 | MALSSDS-PAGE | $125.00 25ug |   |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| AL-002 | AL-002a; AL-002-a; AL-002 | Phase 2 Clinical | Abbvie Inc, Alector Inc | Alzheimer Disease | Details |
| Iluzanebart | VGL-101; VGL 101 | Phase 2 Clinical | Amgen Inc | Posterior Leukoencephalopathy Syndrome; Nerve Degeneration | Details |
| DNL-919 | DNL-919; TAK-920 | Phase 1 Clinical | Denali Therapeutics Inc | Alzheimer Disease | Details |
| VG-3927 | VG-3927 | Phase 1 Clinical | Vigil Neuroscience Inc | Alzheimer Disease | Details |
